JACOBS LEVY EQUITY MANAGEMENT, INC – United Therapeutics Corporation Transaction History
JACOBS LEVY EQUITY MANAGEMENT, INC portfolio value:
$76.55M
portfolio value
JACOBS LEVY EQUITY MANAGEMENT, INC quarter portfolio value change:
-11.14%
quarter
United Therapeutics Corporation 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +10.39% | 34.41K shares | -1.49M | $209.38 | 365.61K |
Q2 2022 | share | Decrease | -4.16% | -14.36K shares | 16.04M | $235.64 | 331.20K |
Q1 2022 | share | Decrease | -10.41% | -40.17K shares | -21.35M | $179.41 | 345.57K |
Q4 2021 | share | Decrease | -20.96% | -102.26K shares | -6.72M | $215.18 | 385.74K |
Q3 2021 | share | Decrease | -0.58% | -2.84K shares | 2.01M | $184.58 | 488.01K |
Q2 2021 | share | Decrease | -2.78% | -14.03K shares | 3.61M | $179.41 | 490.85K |
Q1 2021 | share | Increase | +0.39% | 1.96K shares | 8.11M | $167.27 | 504.89K |
Q4 2020 | share | Decrease | -4.85% | -25.63K shares | 22.95M | $151.79 | 502.93K |
Q3 2020 | share | Increase | +17.13% | 77.30K shares | -1.21M | $101 | 528.56K |
Q2 2020 | share | Increase | +23.77% | 86.67K shares | 20.03M | $121 | 451.25K |
Q1 2020 | share | Increase | +320.44% | 277.86K shares | 26.93M | $94.83 | 364.58K |
Q4 2019 | share | Increase | +924.98% | 78.25K shares | 6.96M | $88.08 | 86.71K |
Q3 2019 | share | Increase | 0.00% | 8.46K shares | 675K | $79.75 | 8.46K |
Q3 2016 | share | Decrease | -100.00% | -24.27K shares | -2.57M | $118.08 | 0 |
Q2 2016 | share | Increase | +158.28% | 14.87K shares | 1.52M | $105.92 | 24.27K |
Q1 2016 | share | Decrease | -76.41% | -30.44K shares | -5.19M | $111.43 | 9.4K |